An exploratory study to evaluate biomarkers of prospective multicenter observational study of atezolizumab in patients with locally advanced or metastatic non-small cell lung cancer :J-TAIL

An exploratory study to evaluate biomarkers of prospective multicenter observational study of atezolizumab in patients with locally advanced or metastatic non-small cell lung cancer :J-TAIL - An exploratory study to evaluate biomarkers of J-TAIL

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035567

Enrollment

250

Registered

2019-01-16

Start date

2019-04-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients enrolled in J-TAIL study and singed informed consent

Exclusion criteria

Exclusion criteria: NONE

Design outcomes

Primary

Measure	Time frame
To evaluate the correlation of values of protein expressions, concentrations of atezolizumab and molecular and functional profiling of T-cell differentiation in peripheral blood with efficacy and safety	—

Countries

Japan

Contacts

Public ContactHayato Konishi

MEBIX INC. CLINICAL OPERATIONS

j-tail@mebix.co.jp03-4362-4504

Outcome results